Case Report: Toxic epidermal necrolysis induced by sintilimab in a patient with advanced lung squamous cell carcinoma

This report highlights the potential for Sintilimab to induce life-threatening TEN, emphasizing the need for vigilant monitoring and prompt intervention during ICIs therapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-29
DOI
https://doi.org/10.3389/fphar.2026.1610305
Citations
1
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
32.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Toxic epidermal necrolysis induced by sintilimab in a patient with advanced lung squamous cell carcinoma

Jiaxing Wu, J. Chen, Mingjun Hu, Wanli Mao et al.
1 citations
Frontiers in Pharmacology
Drug-Induced Adverse Reactions
32.57
article

Case Report: Toxic epidermal necrolysis induced by sintilimab in a patient with advanced lung squamous cell carcinoma

Jiaxing Wu, J. Chen, Mingjun Hu, Wanli Mao, Ailing Wang, Qingqun Wang
article en
1 citations

Abstract

This report highlights the potential for Sintilimab to induce life-threatening TEN, emphasizing the need for vigilant monitoring and prompt intervention during ICIs therapy.

Frontiers in PharmacologyVol. 17
Nankai University (CN), National Cancer Centre Singapore (SG)
Good health and well-being
Openalex Percentile: Top 1%
Drug-Induced Adverse Reactions
32.57
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.